Skandinaviska Enskilda Banken (SEB)’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.36M Hold
59,626
0.01% 558
2025
Q1
$1.8M Hold
59,626
0.01% 589
2024
Q4
$2.08M Hold
59,626
0.01% 568
2024
Q3
$2.39M Hold
59,626
0.01% 553
2024
Q2
$2.85M Hold
59,626
0.01% 486
2024
Q1
$2.58M Hold
59,626
0.01% 521
2023
Q4
$3.02M Hold
59,626
0.02% 489
2023
Q3
$2.71M Hold
59,626
0.02% 472
2023
Q2
$2.45M Buy
59,626
+40,770
+216% +$1.67M 0.02% 511
2023
Q1
$674K Sell
18,856
-880
-4% -$31.5K ﹤0.01% 740
2022
Q4
$745K Sell
19,736
-1,142
-5% -$43.1K 0.01% 699
2022
Q3
$923K Hold
20,878
0.01% 696
2022
Q2
$773K Hold
20,878
0.01% 745
2022
Q1
$773K Hold
20,878
﹤0.01% 791
2021
Q4
$638K Hold
20,878
﹤0.01% 824
2021
Q3
$700K Sell
20,878
-11,415
-35% -$383K ﹤0.01% 837
2021
Q2
$1.29M Sell
32,293
-22,200
-41% -$885K 0.01% 766
2021
Q1
$2.45M Buy
54,493
+10,889
+25% +$490K 0.02% 598
2020
Q4
$2.47M Sell
43,604
-55
-0.1% -$3.11K 0.02% 570
2020
Q3
$2.07M Sell
43,659
-50,941
-54% -$2.42M 0.02% 560
2020
Q2
$5.58M Buy
94,600
+7,200
+8% +$425K 0.05% 307
2020
Q1
$4.13M Sell
87,400
-8,600
-9% -$407K 0.04% 304
2019
Q4
$5.8M Buy
96,000
+1,400
+1% +$84.6K 0.05% 298
2019
Q3
$5.67M Buy
94,600
+86,500
+1,068% +$5.18M 0.05% 300
2019
Q2
$521K Buy
+8,100
New +$521K ﹤0.01% 730
2016
Q2
Sell
-6,400
Closed -$259K 724
2016
Q1
$259K Sell
6,400
-8,300
-56% -$336K ﹤0.01% 677
2015
Q4
$901K Buy
+14,700
New +$901K 0.01% 528